Validation assessment of risk tools to predict outcome after thrombolytic therapy for acute ischemic stroke
Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome